Post on 26-Mar-2015
Supplemental file 3Overall survivals of the entire cohort of patients
20 40 60 80 100
20
40
60
80
100
Overall Survival (months)
Cu
mu
lati
ve S
urv
ival
(%
)
Nasal
Non – nasal
Disseminated
P = 0.011
20 40 60 80 100
20
40
60
80
100
Overall Survival (months)
Cu
mu
lati
ve S
urv
ival
(%
)
Normal ALT
Elevated ALT
P = 0.019
A
B
20 40 60 80 100
20
40
60
80
100
Overall Survival (months)
Cu
mu
lati
ve S
urv
ival
(%
)
Leukemic
Non - leukemic
P = 0.003
20 40 60 80 100
20
40
60
80
100
Overall Survival (months)
Cu
mu
lati
ve S
urv
ival
(%
)
BM negative
BM positive
P < 0.001
C
D
20 40 60 80 100
20
40
60
80
100
Overall Survival (months)
Cu
mu
lati
ve S
urv
ival
(%
)
Stage I
Stage II
Stage IV
P = 0.001
20 40 60 80 100
20
40
60
80
100
Overall Survival (months)
Cu
mu
lati
ve S
urv
ival
(%
)
IPI = 0
IPI = 1
IPI = 3
IPI = 2IPI = 5
IPI = 4
P < 0.001
E
F
20 40 60 80 100
20
40
60
80
100
Overall Survival (months)
Cu
mu
lati
ve S
urv
ival
(%
)
P < 0.001
KIPI = 4
KIPI = 3
KIPI = 2
KIPI = 1KIPI = 0
20 40 60 80 100
20
40
60
80
100
Overall Survival (months)
Cu
mu
lati
ve S
urv
ival
(%
)
EBV group A
EBV group B
EBV group C
P < 0.001
G
H